Neha Patil (Editor)

A 836,339

Updated on
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Covid-19
Legal status  CA: Schedule II
PubChem CID  17754357
UNII  Z6Y1J258EG
Molar mass  310.454 g/mol
CAS Number  959746-77-1
ChemSpider  26286892
Formula  C16H26N2O2S
A-836,339 httpsuploadwikimediaorgwikipediacommonsthu

A-836,339 is a drug developed by Abbott Laboratories that acts as a potent cannabinoid receptor full agonist. It is selective for CB2, with Ki values of 0.64 nM at CB2 vs 270 nM at the psychoactive CB1 receptor, but while it exhibits selective analgesic, anti-inflammatory and anti-hyperalgesic effects at low doses, its high efficacy at both targets results in typical cannabis-like effects appearing at higher doses, despite its low binding affinity for CB1. In 2012 A-836,339 was detected via X-ray crystallography in a "dubious product" sold in Japan, though the product was described as a white powder, not herbal incense, it was suggested to be for human consumption.

References

A-836,339 Wikipedia


Similar Topics
Ente Entethu Mathrem
Michiel Bothma
Momoko Sakura
Topics
 
B
i
Link
H2
L